Possibility of combination therapy using herpes oncolytic virus HF10 with Erlotinib and Gemcitabine as preclinical data for clinical trial

导出原文传递

翻译打印收藏纠错

作者： Kasuya, Hideki ^[1] ; Yamamura, Kazuo ^[2] ; Gewen, Tan ^[3] ; Sahin, Tevfik T. ^[4] ; Hirooka, Yoshihiro ; Goto, Hidemi ; Kodera, Yasuhiro ; Tanaka, Maki

作者单位： Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan ^[1] Takara Bio Inc, Otsu, Shiga 5202193, Japan ^[2] Nagoya Univ Hosp, Dept Endoscopy, Showa Ku, Nagoya, Aichi 4668550, Japan ^[3] Nagoya Univ, Grad Sch Med, Dept Surg 2, Showa Ku, Nagoya, Aichi 4668550, Japan ^[4]

发布时间 2015-03-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Human gene therapy

2014年25卷12期

A3-A3页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Possibility of combination therapy using herpes oncolytic virus HF10 with Erlotinib and Gemcitabine as preclinical data for clinical trial

Human gene therapy

相似文献

Human gene therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Possibility of combination therapy using herpes oncolytic virus HF10 with Erlotinib and Gemcitabine as preclinical data for clinical trial

Human gene therapy

相似文献

Human gene therapy

相关期刊

检索历史清除